References
- Fleming DT, McQuillian GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976–1994. New Engl J Med 1997;337:1105–11
- Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004;11\(Suppl 1): 2A–23A
- Apoola A, Radcilffe K. Antiviral treatment of genital herpes. Int J STD AIDS 2004;15:429–33
- Barton SE, Ebel CE, Kirchner JT, Mertz GJ. The clinical management of recurrent genital herpes: current issues and future prospects. Herpes 2002;9:15–20
- Drob S, Loemer M, Lifshutz H. Genital herpes: the psychological consequences. Br J Med Psychol 1985;58:307–15
- Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006;20:73–83
- Brown ZA, Kern ER, Spruance SL, Overall Jr JC. Clinical and virologic course of herpes simplex genitalis. West J Med 1979;130:414–21
- Spruance SL. Herpes simplex labialis. In: Sacks SL, Straus SE, Whitley RJ, Griffiths PD, editors. Clinical management of herpes viruses. Amsterdam, Netherlands: IOS Press, 1995; p.3–42
- Aoki FY, Tyring S, Diaz-Mitoma F, et al. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double blind, placebo-controlled trial. Clin Infect Dis 2006;42:8–13
- Diaz-Mitoma F, Sibbald G, Shafran SD, et al. Oral famciclovir for the suppression of recurrent genital herpes. A randomized controlled trial. J Am Med Assoc 1998;280:887–92
- Reitano M, Tyring S, Lang W, et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. J Infect Dis 1998;178: 603–10
- Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. New Engl J Med 2004;350:11–20
- Reichman RC, Badger GJ, Guinan ME, et al. Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. J Infect Dis 1983;147: 336–40
- Reichman RC, Badger GJ, Mertz GJ, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. J Am Med Assoc 1984;251:2103–7
- Wald A, Carrell D, Remington M, et al. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002;34:944–8
- Valtrex package insert. Glaxo Smith Kline, Research Triangle Park, NC. 2005
- Tyring SK, Douglas Jr JM, Corey L, et al. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections [The Valaciclovir International Study Group]. Arch Dermatol 1998;134:185–91
- Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002;34: 958–62
- Pue MA, Benet MA. Pharmacokinetics of famciclovir in man. Antivir Chem Chemother 1993;4(Suppl 1):47–55
- Sacks S, Aoki F, Diaz-Mitoma F, et al. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. J Am Med Assoc 1996;276:44–9